IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech

Displaying 401 - 420 of 1620 stories.
May 23, 2012
Novozymes says it has been chosen to supply enzymes to Brazil's first cellulosic ethanol facility. The 22 million gals/year plant, announced earlier today by GraalBio and Chemtex, is...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Novozymes-Selected-for-Cellulosic-Ethanol-Project-Considering-Brazilian-Enzyme-Manufacturing-Plant_43710.html
May 22, 2012
Codexis (Redwood City), an enzymes technology firm, says Merck has signed a three-year extension to an ongoing catalyst and process development collaboration for pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-Extends-Enzymes-Collaboration-with-Codexis_43675.html
May 22, 2012
MITSUBISHI TANABE PHARMA EXITS FINE CHEMICALS BUSINESS Mitsubishi Tanabe Pharma (Osaka, Japan) says it will exit the fine chemicals business and transfer its fine chemical operations...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-22_43661.html
May 21, 2012
Mitsubishi Tanabe Pharma (Osaka, Japan) says it will exit the fine chemicals business and transfer its fine chemical operations to two companies. Mitsubishi Tanabe Pharma’s...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Tanabe-Pharma-Exits-Fine-Chemicals-Business_43627.html
May 18, 2012
Agchem firm Nufarm (Melbourne) says it has changed its European management structure, and has appointed Hugo Schweers as executive general manager/Europe, effective July 1, 2012...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Nufarm-Appoints-Head-of-European-Operations_43578.html
May 17, 2012
Codexis (Redwood City, CA) says that the United States Patent and Trademark Office (USPTO; Alexandria, VA) has granted Codexis’ patent covering the biocatalysts and biocatalytic...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/USPTO-Grants-Codexis-Patent-for-Enzymes-Used-in-Hepatitis-C-Therapeutics_43535.html
May 16, 2012
GlaxoSmithKline (GSK; London) says it has entered into an agreement to acquire those shares it does not currently own in privately held Cellzome (Heidelberg, Germany), a leader in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GSK-Acquires-Chemical-Proteomics-Company_43494.html
May 16, 2012
Lonza and Avalanche Biotechnologies (San Francisco, CA), a privately held biotechnology company, have formed a manufacturing collaboration focused on process development and scale-up...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-and-Avalanche-Biotechnologies-Form-Manufacturing-Collaboration_43493.html
May 15, 2012
BASF ACQUIRES EQUATEQ, A MANUFACTURER OF OMEGA-3 FATTY ACIDS FOR PHARMACEUTICALS BASF says it has acquired Equateq (Isle of Lewis, U.K.), a global leader in the manufacturing of highly...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-15_43470.html
May 15, 2012
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific Corp. (Las Vegas, NV), has recorded an operating loss of about $1 million in its fiscal second quarter...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-Reports-an-Operating-Loss_43469.html
May 15, 2012
Asahi Glass (Tokyo) says it has decided to invest about ¥800 million ($10 million) to build a new production line for Tafluprost, an active pharmaceutical ingredient (API) for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Asahi-Glass-to-Double-Production-Capacity-for-Tafluprost-API_43468.html
May 15, 2012
Hikal (Mumbai), an outsourcing partner to companies in the pharma, biotech, agchem, and specialty chemical industries, has recorded a 7% increase in net profits for its fiscal fourth...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hikal-Reports-Rise-in-Profits-and-Sales_43467.html
May 14, 2012
Chemical companies are seeing an increase in opportunities to swap oil and natural gas with renewable raw materials due to the availability of viable, low-cost production processes...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Momentum-Builds-Behind-Viable-Biobased-Technologies_43386.html
May 14, 2012
Virdia (Redwood City, CA) opened its demonstration facility at its new technology center at Danville, VA on April 25. The facility exhibits the company’s CASE (Cold Acid Solvent...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Virdia-Opens-Demonstration-Facility-at-Technology-Center-in-Virginia_43411.html
May 11, 2012
ADM’s (Decatur, IL) third-quarter 2012, ending March 31, net earnings fell 31% year-on-year, to $399 million.  Adjusted earnings fell 12%, to 78 cts/share and include the...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/ADMs-Third-Quarter-Earnings-Fall-Sales-Increase_43363.html
May 9, 2012
Novozymes says its Novozymes Biopharma business has begun commercial supply of hyaluronic acid from a previously announced new plant at Tianjin, China. The newly opened plant involved...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novozymes-Opens-Hyaluronic-Acid-Plant-in-China_43308.html
May 9, 2012
BASF says it has acquired Equateq (Isle of Lewis, U.K.), a global leader in the manufacturing of highly concentrated omega-3 fatty acids. Financial details of the deal were not...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-Acquires-Equateq-a-Manufacturer-of-Omega-3-Fatty-Acids-for-Pharmaceuticals_43304.html
May 8, 2012
LONZA ON TRACK TO MEET 2012 TARGETS Lonza, in its business update announcement for the first quarter of 2012, says that the company’s business performance was in line with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-8_43278.html
May 8, 2012
DSM says that the performance of the company’s pharmaceutical business in the first quarter of 2012 remained weak, although first signs of improvement are visible. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSMs-Pharma-Business-Reports-Weak-Results-in-First-Quarter_43275.html
Pages: « Previous  12 13 14 15 16 17 18 19 20 [21] 22 23 24 25 26 27 28 29 30 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa